Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab in Adult-Onset Still's Disease
NCT01002781Phase 2Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Nov 2009
- Primary completion
- Jul 2011
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 2 trial of tocilizumab in adult-onset Still's disease (AOSD), sponsored by Tel Aviv Sourasky Medical Center. Status: unknown.
02
Drugs
tocilizumab
03
Conditions
adult-onset Still's disease (AOSD)
Beyond the preview
Go deeper on NCT01002781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01002781.